Swiss National Bank Replimune Group, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Replimune Group, Inc. stock. As of the latest transaction made, Swiss National Bank holds 65,900 shares of REPL stock, worth $728,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,900

Previous 84,500 22.01%

Holding current value

$728,195

Previous $760,000 5.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$8.09 - $11.23 $150,474 - $208,878	-18,600 Reduced 22.01%	65,900 $722,000
Q2 2024 Aug 08, 2024	BUY	$5.01 - $9.46 $73,647 - $139,062	14,700 Added 21.06%	84,500 $760,000
Q4 2023 Feb 06, 2024	SELL	$6.75 - $16.18 $43,875 - $105,170	-6,500 Reduced 8.52%	69,800 $588,000
Q3 2023 Nov 08, 2023	SELL	$15.96 - $22.18 $62,244 - $86,502	-3,900 Reduced 4.86%	76,300 $1.31 Million
Q2 2023 Aug 09, 2023	BUY	$15.65 - $24.1 $45,385 - $69,890	2,900 Added 3.75%	80,200 $1.86 Million
Q1 2023 May 10, 2023	SELL	$17.48 - $29.09 $148,580 - $247,265	-8,500 Reduced 9.91%	77,300 $1.37 Million
Q4 2022 Feb 08, 2023	BUY	$17.09 - $27.91 $471,684 - $770,316	27,600 Added 47.42%	85,800 $2.33 Million
Q3 2022 Nov 09, 2022	BUY	$15.6 - $21.15 $40,560 - $54,989	2,600 Added 4.68%	58,200 $1.01 Million
Q2 2022 Aug 09, 2022	BUY	$13.32 - $19.98 $75,924 - $113,886	5,700 Added 11.42%	55,600 $972,000
Q1 2022 May 09, 2022	BUY	$15.24 - $29.75 $57,912 - $113,050	3,800 Added 8.24%	49,900 $847,000
Q2 2021 Aug 06, 2021	SELL	$28.5 - $39.37 $182,400 - $251,967	-6,400 Reduced 12.19%	46,100 $1.77 Million
Q1 2021 May 07, 2021	BUY	$30.22 - $45.57 $51,374 - $77,469	1,700 Added 3.35%	52,500 $1.6 Million
Q4 2020 Feb 05, 2021	BUY	$23.5 - $52.65 $615,700 - $1.38 Million	26,200 Added 106.5%	50,800 $1.94 Million
Q2 2020 Aug 05, 2020	BUY	$9.76 - $25.95 $240,096 - $638,370	24,600 New	24,600 $611,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $545M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Replimune Group, Inc. Transaction History